Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial

Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Core content updated: new operating-status notice and version 3.2.0; previous version 3.1.0 removed.
    Difference
    13%
    Check dated 2025-10-06T04:44:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T01:30:57.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.0.2 added; previous v3.0.1 removed, and the 'Back to Top' element was deleted.
    Difference
    0.8%
    Check dated 2025-09-14T18:51:22.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.8%
    Check dated 2025-09-07T13:38:12.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    9%
    Check dated 2025-08-31T11:33:52.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T01:32:26.000Z thumbnail image

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.